Evidence map›Paper›PMID 30242782›Full record

ArticleThe Psychiatric quarterly2019

Factors Affecting the Management of Somatic Comorbidity in Tunisian Patients with Schizophrenia.

Jihene Ben Thabet, Nada Charfi, Wafa Dalhoum, Sourour Yaich, Manel Maâlej Bouali, Sana Omri, Nasreddine Zouari, Lobna Zouari, Jamel Damak, Mohamed Maâlej

Abstract read
PubMed Publisher
In one paragraph

Article in The Psychiatric quarterly, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jihene Ben ThabetPsychiatry « C » Department, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.
Nada CharfiPsychiatry « C » Department, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia. nada_charfi@yahoo.fr.ORCID http://orcid.org/0000-0003-0675-528X
Wafa DalhoumSouk Jdid Hospital, Sidi Bouzid, Tunisia.
Sourour YaichDepartment of Preventive Medicine, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.
Manel Maâlej BoualiPsychiatry « C » Department, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.
Sana OmriPsychiatry « C » Department, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.
Nasreddine ZouariPsychiatry « C » Department, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.
Lobna ZouariPsychiatry « C » Department, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.
Jamel DamakDepartment of Preventive Medicine, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.
Mohamed MaâlejPsychiatry « C » Department, University Hospital Hedi Chaker, University of Sfax, Sfax, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is often accompanied by somatic comorbidities, which make the management challenge of such patients more difficult. In this study, we proposed to identify the sociodemographic and clinical factors correlating with somatic comorbidities in patients with schizophrenia to facilitate screening and prevention. It was a retrospective descriptive study of 78 schizophrenia patients in clinical remission and followed in outpatient psychiatry. In addition to the acquired records, other data were provided by the clinical and biological examinations performed for each patient. The evaluation of the therapeutic adherence was carried out using the Drug Attitude Inventory (DAI).Seventy-six patients (97.4%) had somatic comorbidities with a mean of 3.83 (± 1.81). This number increased significantly in males, older patients, couples, urban patients, and those receiving a combination therapy. According to a multivariate study, the four predictors of an increased risk of comorbidities were age, use of psychoactive substances, waist size and therapeutic adherence.Our findings focus on somatic comorbidities risk in schizophrenia patients, requiring particular vigilance in their follow-up, and suggest some modifiable clinical factors that might be a preferred target for reducing or preventing the occurrence of such disorders.

Indexed as

AdultComorbidityFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSchizophreniaSomatoform DisordersTunisiaYoung AdultComorbidityRisk factorsSchizophreniaSomatic

Identifiers

PMID30242782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.